CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-14 | Anglum Gregory O. SVP & CFO | Sale | −1,294 | $11.99 | $16K | 55,013 |
| 2022-02-11 | Anglum Gregory O. SVP & CFO | Exercise or conversion | +4,400 | 56,307 | ||
| 2022-02-11 | Anglum Gregory O. SVP & CFO | Exercise or conversion · Restricted Stock Units | −4,400 | 0 | ||
| 2022-02-10 | Anglum Gregory O. SVP & CFO | Exercise or conversion | +65,581 | 71,581 | ||
| 2022-02-10 | Anglum Gregory O. SVP & CFO | Shares withheld for taxes | +19,674 | $12.88 | $253K | 51,907 |
| 2022-02-10 | Anglum Gregory O. SVP & CFO | Exercise or conversion · Phantom Profit Units | −65,581 | 0 | ||
| 2021-04-01 | Anglum Gregory O. SVP & General Counsel | Grant or award · Restricted Stock Units | +96,876 | 96,876 | ||
| 2021-04-01 | Anglum Gregory O. SVP & General Counsel | Grant or award · Stock Options | +9,100 | 9,100 | ||
| 2021-02-11 | Anglum Gregory O. SVP & General Counsel | Purchase | +6,000 | $13.00 | $78K | 6,000 |
| 2021-02-11 | Anglum Gregory O. SVP and CFO | Grant or award · Restricted Stock Units | +4,400 | 4,400 |
Page 1 of 1 · 10 trades